Total Payments
$4,597
2024 Payments
$1,240
Companies
45
Transactions
193
Medicare Patients
989
Medicare Billing
$84,761
Payment Breakdown by Category
Food & Beverage$4,575 (99.5%)
Other$22.43 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,575 | 192 | 99.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22.43 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SK Life Science, Inc. | $702.38 | 26 | $0 (2024) |
| Neurelis, Inc. | $516.37 | 24 | $0 (2023) |
| UCB, Inc. | $431.23 | 17 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $385.09 | 16 | $0 (2024) |
| LivaNova USA, Inc. | $326.17 | 6 | $0 (2024) |
| CATALYST PHARMACEUTICALS, INC. | $233.38 | 13 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $177.10 | 8 | $0 (2024) |
| Eisai Inc. | $137.71 | 7 | $0 (2023) |
| ARGENX US, INC. | $125.59 | 4 | $0 (2024) |
| Amgen Inc. | $106.77 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,240 | 48 | SK Life Science, Inc. ($197.51) |
| 2023 | $1,481 | 53 | SK Life Science, Inc. ($283.64) |
| 2022 | $1,238 | 56 | SK Life Science, Inc. ($221.23) |
| 2021 | $326.61 | 18 | Neurelis, Inc. ($107.53) |
| 2020 | $87.79 | 5 | UCB, Inc. ($37.93) |
| 2019 | $120.65 | 6 | Astellas Pharma US Inc ($47.43) |
| 2018 | $42.86 | 3 | Lundbeck LLC ($17.20) |
| 2017 | $59.64 | 4 | Acorda Therapeutics, Inc ($22.43) |
All Payment Transactions
193 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $23.22 | General |
| Category: NEUROLOGY | ||||||
| 10/10/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Rare Disease | ||||||
| 10/09/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 09/26/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $24.47 | General |
| 09/12/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Neurology | ||||||
| 09/04/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/03/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $17.98 | General |
| Category: NEUROLOGY | ||||||
| 08/28/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $31.34 | General |
| Category: Neurology | ||||||
| 08/22/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Central Nervous System | ||||||
| 08/14/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $22.14 | General |
| Category: NEUROLOGY | ||||||
| 08/02/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $37.36 | General |
| Category: Genetic Disease | ||||||
| 07/31/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 07/30/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $43.03 | General |
| Category: Neurology | ||||||
| 07/25/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Rare Disease | ||||||
| 07/17/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $127.27 | General |
| Category: Neurology | ||||||
| 07/17/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $20.08 | General |
| Category: NEUROLOGY | ||||||
| 07/16/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $34.11 | General |
| Category: Narcoplepsy | ||||||
| 06/19/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $33.10 | General |
| 05/29/2024 | Novartis Pharmaceuticals Corporation | ZOLGENSMA (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Neurology | ||||||
| 05/20/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $21.98 | General |
| Category: NEUROLOGY | ||||||
| 05/20/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $21.61 | General |
| Category: NEUROLOGY | ||||||
| 05/20/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $0.12 | General |
| Category: NEUROLOGY | ||||||
| 05/15/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: Neurology | ||||||
| 05/09/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $32.79 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 298 | 328 | $88,865 | $24,039 |
| 2022 | 9 | 378 | 435 | $122,314 | $31,671 |
| 2021 | 9 | 288 | 313 | $87,757 | $24,836 |
| 2020 | 2 | 25 | 35 | $13,495 | $4,216 |
Total Patients
989
Total Services
1,111
Medicare Billing
$84,761
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 34 | 54 | $27,540 | $8,212 | 29.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 85 | 86 | $21,414 | $3,429 | 16.0% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Facility | 2023 | 48 | 50 | $13,800 | $3,140 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 28 | 30 | $5,160 | $2,047 | 39.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 17 | 18 | $4,410 | $1,949 | 44.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 14 | 14 | $5,152 | $1,793 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 36 | 40 | $4,440 | $1,519 | 34.2% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 12 | 12 | $3,948 | $1,226 | 31.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 13 | 13 | $2,275 | $474.87 | 20.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 11 | 11 | $726.00 | $248.67 | 34.3% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 46 | 84 | $42,840 | $12,744 | 29.7% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 130 | 135 | $33,615 | $5,515 | 16.4% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Facility | 2022 | 44 | 48 | $13,248 | $3,102 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 50 | 58 | $6,438 | $2,391 | 37.1% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 22 | 23 | $7,567 | $2,363 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 35 | 36 | $6,192 | $2,061 | 33.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 14 | 14 | $3,430 | $1,333 | 38.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 13 | 13 | $4,784 | $1,185 | 24.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 24 | 24 | $4,200 | $977.05 | 23.3% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 35 | 51 | $26,010 | $8,000 | 30.8% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 109 | 111 | $27,639 | $4,797 | 17.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 37 | 38 | $9,310 | $3,981 | 42.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 16 | 16 | $5,888 | $2,074 | 35.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 24 | 26 | $4,472 | $1,931 | 43.2% |
| 95813 | Measurement of brain wave activity (eeg) extended monitoring, 61-119 minutes | Facility | 2021 | 18 | 19 | $5,244 | $1,285 | 24.5% |
About Dr. Danielle Weiss, MD
Dr. Danielle Weiss, MD is a Epilepsy healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2015. The National Provider Identifier (NPI) number assigned to this provider is 1528454402.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danielle Weiss, MD has received a total of $4,597 in payments from pharmaceutical and medical device companies, with $1,240 received in 2024. These payments were reported across 193 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($4,575).
As a Medicare-enrolled provider, Weiss has provided services to 989 Medicare beneficiaries, totaling 1,111 services with total Medicare billing of $84,761. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Epilepsy
- Other Specialties Neurology, Epilepsy
- Location Augusta, GA
- Active Since 04/08/2015
- Last Updated 12/06/2022
- Taxonomy Code 2084E0001X
- Entity Type Individual
- NPI Number 1528454402
Products in Payments
- VALTOCO (Drug) $516.37
- EPIDIOLEX (Drug) $357.71
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $307.73
- FYCOMPA (Drug) $233.38
- Briviact (Drug) $224.74
- Fycompa (Drug) $137.71
- Aimovig (Biological) $106.77
- Fintepla (Drug) $104.72
- VILTEPSO (Drug) $102.94
- VYVGART HYTRULO (Drug) $101.32
- SOLIRIS (Biological) $86.54
- RADICAVA (Drug) $85.48
- SPINRAZA (Biological) $81.64
- Rystiggo (Drug) $81.05
- NURTEC ODT (Drug) $78.25
- RNS Neurostimulator Kit (Device) $70.49
- ULTOMIRIS (Biological) $64.40
- WAKIX (Drug) $56.12
- APTIOM (Drug) $50.85
- TROKENDI XR (Drug) $48.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.